Proactively managing the risk of marketed drugs: Experience with the EMA Pharmacovigilance Risk Assessment Committee

Peter Arlett; Geraldine Portier; Roberto De Lisa; Kevin Blake; Noel Wathion; Jean-Michel Dogné; Almath Spooner; June Raine; Guido Rasi

doi:10.1038/nrd3713-c1

Proactively managing the risk of marketed drugs: Experience with the EMA Pharmacovigilance Risk Assessment Committee

Peter Arlett, Geraldine Portier, Roberto De Lisa, Kevin Blake, Noel Wathion, Jean-Michel Dogné, Almath Spooner, June Raine, Guido Rasi

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	395-397
Number of pages	3
Journal	Nature Reviews Drug Discovery
Volume	13
Issue number	5
DOIs	https://doi.org/10.1038/nrd3713-c1
Publication status	Published - 1 Jan 2014

Access to Document

10.1038/nrd3713-c1

Cite this

@article{fffd18afe735495f80353cf28bd74e00,

title = "Proactively managing the risk of marketed drugs: Experience with the EMA Pharmacovigilance Risk Assessment Committee",

author = "Peter Arlett and Geraldine Portier and \{De Lisa\}, Roberto and Kevin Blake and Noel Wathion and Jean-Michel Dogn{\'e} and Almath Spooner and June Raine and Guido Rasi",

year = "2014",

month = jan,

day = "1",

doi = "10.1038/nrd3713-c1",

language = "English",

volume = "13",

pages = "395--397",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

publisher = "Nature Research",

number = "5",

}

TY - JOUR

T1 - Proactively managing the risk of marketed drugs

T2 - Experience with the EMA Pharmacovigilance Risk Assessment Committee

AU - Arlett, Peter

AU - Portier, Geraldine

AU - De Lisa, Roberto

AU - Blake, Kevin

AU - Wathion, Noel

AU - Dogné, Jean-Michel

AU - Spooner, Almath

AU - Raine, June

AU - Rasi, Guido

PY - 2014/1/1

Y1 - 2014/1/1

UR - https://www.scopus.com/pages/publications/84899949148

U2 - 10.1038/nrd3713-c1

DO - 10.1038/nrd3713-c1

M3 - Letter

C2 - 24751815

AN - SCOPUS:84899949148

SN - 1474-1776

VL - 13

SP - 395

EP - 397

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

IS - 5

ER -

Proactively managing the risk of marketed drugs: Experience with the EMA Pharmacovigilance Risk Assessment Committee

Access to Document

Other files and links

Cite this